Latest Contract Manufacturing News

Page 3 of 11
Vitrafy Life Sciences has secured its first US cell and gene therapy foothold by deploying its cryopreservation technology at Charter Medical's Innovation Hub, signalling a strategic expansion into a high-value biopharma segment.
Ada Torres
Ada Torres
2 Sept 2026
Peak Processing Limited’s FY26 results reveal a doubling loss from continuing operations to $10 million amid a $4.35 million impairment, offset partially by a $2.5 million profit from discontinued operations. The company completed an operational reset and posted its first positive EBITDA quarter in June 2026.
Victor Sage
Victor Sage
31 Aug 2026
Wide Open Agriculture cut its loss to $3.64 million in FY2026 as it pivots from owning manufacturing to a capital-light contract model, while securing global commercial traction for its lupin-based ingredients.
Ada Torres
Ada Torres
31 Aug 2026
Cambium Bio has secured FDA agreement on a streamlined single pivotal Phase 3 trial for Elate Ocular®, cutting development costs and timelines. Despite a AUD 4.1 million loss for FY2026, the company strengthened its funding position and manufacturing partnerships ahead of patient dosing targeted for late 2026.
Ada Torres
Ada Torres
28 Aug 2026
6K Additive surged to a US$13.3 million half-year revenue, up 73% year-on-year, driven by strong demand in its Powder and Alloy segments. The company is on track to nearly quadruple production capacity by the end of 2026, supported by substantial US government funding and a new EXIM loan facility.
Victor Sage
Victor Sage
26 Aug 2026
NeuroScientific Biopharmaceuticals posted a $4.69 million loss for FY2026, driven by R&D ramp-up and clinical progress with its StemSmart™ platform, while halting independent development of its glaucoma drug EmtinB to pursue licensing deals.
Ada Torres
Ada Torres
25 Aug 2026
Entropy Neurodynamics has partnered with BioCina to establish GMP manufacturing for its intravenous psilocin formulation TRP-8803, a critical step toward late-stage clinical trials and commercialisation.
Ada Torres
Ada Torres
19 Aug 2026
Wide Open Agriculture (ASX: WOA) has taken a significant step towards a capital-light production model by signing a non-binding framework agreement with Proeon Foods for contract manufacturing of its lupin-based ingredients, including exclusive Indian distribution rights.
Ada Torres
Ada Torres
10 Aug 2026
Wellnex Life has agreed to sell its Pain Away brand to Mentholatum Australasia for up to A$21.3 million, aiming to wipe out debt and sharpen its strategic focus.
Ada Torres
Ada Torres
6 Aug 2026
Structural Monitoring Systems Plc (ASX: SMN) reported a milestone FY26 with record revenue of $32.5 million and net profit rising to $1.2 million, driven by strong avionics growth and progressing FAA certification for its CVMTM smart sensor technology.
Victor Sage
Victor Sage
31 July 2026
The Calmer Co. has signed a binding heads of agreement with Kaiming Agro Processing to establish a long-term manufacturing partnership, leveraging advanced extraction technology in Fiji to scale its premium botanical ingredients business globally.
Victor Sage
Victor Sage
30 July 2026
Wide Open Agriculture (ASX: WOA) is executing a major strategic pivot by closing its German production site and transitioning to a capital-light contract manufacturing model to improve economics and scale lupin protein production.
Ada Torres
Ada Torres
28 July 2026

Browse the archive

Full archive